GlassScriptPhysician profile
Anitha V Shrikhande
NPI 1770788911
$1,686.95
in general payments reported to CMS, 2019-2025
22 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Allergy provider received nationally (typical 2025 total: $1,129).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $320 · 2021: $697 · 2022: $14.08 · 2023: $65.49 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $375.60 | 2019-2023 | Tezspire |
| Glaxosmithkline, LLC. | $291.58 | 2019-2025 | Nucala |
| Genzyme Corporation | $284.44 | 2019-2021 | |
| Aquestive Therapeutics, INC. | $119.22 | 2025 | |
| Pharming Healthcare, INC. | $116.92 | 2025 | Ruconest |
| Grifols USA, LLC | $63.60 | 2019-2020 | |
| Pfizer INC. | $61.95 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $57.12 | 2021 | |
| Kaleo, INC. | $53.89 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $49.09 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $30.30 | 2020-2021 | |
| Aimmune Therapeutics, INC. | $26.85 | 2021 | |
| Biocryst US Sales Co., LLC | $25.69 | 2021 | |
| Novartis Pharmaceuticals Corporation | $22.98 | 2019 | |
| Genentech USA, INC. | $15.80 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.94 | 2021 | |
| Optinose US, INC. | $14.09 | 2021 | |
| Csl Behring | $13.94 | 2019 | |
| Sunovion Pharmaceuticals INC. | $12.88 | 2019 | |
| Merck Sharp & Dohme LLC | $12.43 | 2021 | |
| Uswm, LLC | $12.32 | 2021 | |
| Incyte Corporation | $11.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anitha Shrikhande listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.